×

Hexaxim

Hexaxim

Diphtheria toxoid not <20 IU; tetanus toxoid not <40 IU; Bordetella pertussis antigens: Pertussis toxoid 25 mcg, filamentous haemagglutinin 25 mcg; inactivated poliovirus: Type 1 (Mahoney) 40 D-antigen units, type 2 (MEF-1) 8 D-antigen units, type 3 (Saukett) 32 D-antigen units; hepatitis B surface antigen 10 mcg; H. influenzae type b polysaccharide (polyribosylribitol phosphate) 12 mcg, conjugated to tetanus protein 22-36 mcg

Categories: ,

Description

The active substances are per dose (0.5 ml)1: Diphtheria Toxoid not less than 20 IU2, Tetanus Toxoid not less than 40 IU2, Bordetella pertussis antigens (Pertussis Toxoid 25 micrograms, Filamentous Haemagglutinin 25 micrograms), Poliovirus (Inactivated)3 Type I (Mahoney) 40 D antigen units4, Type 2 (MEF-I) 8 D antigen units4, Type 3 (Saukett) 32 D antigen units4, Hepatitis B surface antigen5 10 micrograms, Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) 12 micrograms, conjugated to Tetanus protein 22-36 micrograms.
1Adsorbed on aluminum hydroxide, hydrated (0.6 mg Al3+).
2IU International Unit.
3Produced on Vero cells.
4Equivalent antigenic quantity in the vaccine.
5Produced in yeast Hansenula polymorpha cells by recombinant DNA technology.

Related products